Al-Ola Abdallah, Associate Professor and Plasma Cell Disorder Program Director of the Division of HMCT at the University of Kansas Medical Center, shared a post on X:
“China vs USA in Myeloma CAR-T trials this year!!!!
It’s time for academic centers to lead the way by launching prospective CAR-T trials.”
More posts featuring Al-Ola Abdallah.